Cohance Lifesciences Limited (NSE:COHANCE)
India flag India · Delayed Price · Currency is INR
324.50
+15.75 (5.10%)
Feb 18, 2026, 3:29 PM IST

Cohance Lifesciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
118,118293,004172,366120,256157,436126,468
Market Cap Growth
-54.30%69.99%43.33%-23.61%24.49%394.20%
Enterprise Value
119,989287,341165,176117,048156,449127,128
Last Close Price
308.751151.00677.10472.40608.53484.99
PE Ratio
131.40109.3857.4029.2434.6934.90
Forward PE
40.9580.6844.4026.2330.4829.75
PS Ratio
10.9524.4716.408.9711.9312.53
PB Ratio
3.0115.928.406.9310.3110.71
P/TBV Ratio
4.8529.978.677.1910.3210.73
P/FCF Ratio
-221.2251.7870.2161.7946.55
P/OCF Ratio
-101.6844.8026.3047.7133.06
EV/Sales Ratio
11.1223.9915.718.7311.8512.59
EV/EBITDA Ratio
75.1270.8540.3920.4427.0028.85
EV/EBIT Ratio
184.3787.5846.6122.2528.8931.02
EV/FCF Ratio
-216.9449.6268.3461.4046.79
Debt / Equity Ratio
0.120.150.030.040.060.12
Debt / EBITDA Ratio
2.820.690.160.120.170.32
Debt / FCF Ratio
-2.110.200.410.380.53
Net Debt / Equity Ratio
0.010.00-0.37-0.24-0.28-0.04
Net Debt / EBITDA Ratio
0.320.01-1.85-0.72-0.74-0.10
Net Debt / FCF Ratio
-0.02-2.27-2.41-1.68-0.16
Asset Turnover
-0.450.500.710.800.76
Inventory Turnover
-1.851.321.872.242.19
Quick Ratio
-1.788.614.173.851.56
Current Ratio
-2.4310.686.375.362.57
Return on Equity (ROE)
-13.61%15.86%25.21%33.52%35.78%
Return on Assets (ROA)
-7.76%10.50%17.33%20.49%19.35%
Return on Invested Capital (ROIC)
1.31%16.10%20.05%31.95%32.95%29.89%
Return on Capital Employed (ROCE)
-12.30%16.60%29.10%33.40%32.70%
Earnings Yield
0.51%0.91%1.74%3.42%2.88%2.86%
FCF Yield
-0.45%1.93%1.42%1.62%2.15%
Dividend Yield
---0.64%0.33%0.41%
Payout Ratio
---49.52%22.44%7.03%
Buyback Yield / Dilution
0.07%-0.49%-0.00%0.00%0.00%
Total Shareholder Return
0.07%-0.49%-0.64%0.33%0.41%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.